Day: January 12, 2022

New York, NY, and Tel Aviv, ISRAEL, Jan. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF),a comprehensive medical diagnostics and related solutions company, together with its 3CL biology-focused joint venture partner NLC Pharma, today announced that topline results from the Tollovir™ Phase 2 clinical trial for the treatment of hospitalized COVID-19 patients will be announced the morning of January 27th, 2022, with a conference call follow-up that will occur after market close. The Company will provide further details regarding the conference call during the week ending January 17, 2022 when it announces the data lock for the trial. For more information, please visit www.todosmedical.com. For more information on the Company’s CLIA/CAP certified lab Provista Diagnostics, Inc. please visit www.provistadx.com. About...

Miami, FL, Jan. 12, 2022 (GLOBE NEWSWIRE) — Save Foods (NASDAQ: SVFD) (“Save Foods” or the “Company”), an Israeli Agri-Food Tech company specializing in eco crop protection, today announced its Israeli subsidiary, Save Foods Ltd., has hired Mia Serra as its new Chief Marketing Officer. The addition of a marketing, IR & PR executive comes as Save Foods prepares to ramp up worldwide distribution of its product that dramatically reduces food waste and increases produce shelf life. Mia brings more than 15 years of marketing experience to Save Foods, where she will be in charge of brand strategy and all marketing communications. She will also be involved in the Company’s investor and public relations programs, providing timely insights into the Company’s progress and sharing important milestone with investors. Mia has extensive...

NEW YORK, Jan. 12, 2022 (GLOBE NEWSWIRE) — via InvestorWire — One of the most important advantages of the internet is making the world a global village. This has revolutionized how people learn, work, buy and sell, love, and experience things with others. While businesses of all sizes are already leveraging the many advantages, many are still left out or not exploring it to its full potential. A new online portal, the Integrated Micro, Small & Medium Enterprise (iMSME) ecosystem is being developed to close this gap.  iMSME will be a portal open to businesses of all sizes, with a focus on SMEs, designed to facilitate communication among businesses and to build relationships with potential partners, clients and customers.  The portal is a product of a partnership endeavor between business solutions company, ITScope Consulting,...

NEW YORK, Jan. 12, 2022 (GLOBE NEWSWIRE) — Mizuho Americas today announced the hiring of Graig Suvannavejh, PhD, as Managing Director, Senior Biopharmaceuticals and Biotechnology Equity Research Analyst. Suvannavejh joins an experienced, global healthcare equity research team that includes US based Biotechnology Senior Analysts Mara Goldstein and Salim Syed, Biopharmaceuticals and Biotechnology Senior Analyst Vamil Divan and Analyst Uy Ear, Healthcare Services Senior Analyst Ann Hynes, with Barron Willard, Healthcare trader based in NY. The Japan based team includes Pharmaceuticals Analyst Hiroshi Tanaka, Pharmaceuticals and Biotechnology analyst Shinya Tsuzuki, and Medical Technologies and Services Analysts Takahiro Mori and Kazuki Furuyama. Dr. Suvannavejh will be based in New York and report to Managing Director and Head of...

NEW YORK, Jan. 12, 2022 (GLOBE NEWSWIRE) — MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that Dr. Jennifer Buell, President and CEO of MiNK, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference on January 27th, 2022, at 12:00 pm ET. Access to the live presentation is available at https://www.webcaster4.com/Webcast/Page/2828/44096 A replay will be available after the call on the Events and Presentations page of the MiNK website at https://investor.minktherapeutics.com/events-and-presentations About MiNK TherapeuticsMiNK Therapeutics is a clinical-stage biopharmaceutical...

Dallas, Texas, Jan. 12, 2022 (GLOBE NEWSWIRE) — Vaycaychella, Inc. (OTC Pink: VAYK) today announced the company will publish a presentation this Friday, Jan 14th, on the company’s rapid expansion plans for 2022.  Management anticipates the timing of VAYK’s alternative P2P real estate financing application coinciding with anticipated interest rate increases in 2022 to enhance VAYK’s opportunity for growth.  The presentation on Friday will address the enhanced opportunity and other market conditions VAYK management anticipates as beneficial to the company’s 2022 outlook. The presentation will also include the latest update on the timing the P2P Alt Real Estate Finance Vaycaychella App Version 2.0.  To learn more and keep up with the latest updates at Vaycaychella, and to access the Vaycaychella App, visit  https://www.vaycaychella.com/....

Q3 Sales of $4.4M, Up 15% Year-over-Year; Record Backlog of $6.5M, up 69% from FYE February 28, 2021 MILTON, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the third quarter and first nine-month periods of fiscal year 2022, ended November 30, 2021. Third Quarter Fiscal 2022 Highlights (compared with the third quarter of fiscal 2021 unless otherwise noted). Net sales increased 15% to $4,419,000, driven by strong sales to Asia for medical device coating machines and clean energy coating systems. Gross Profit increased 12% to $2,159,000 due to the increase in sales. Gross Margin was 48.9% compared with 50.5% for the prior year period due to changes in product mix. Operating...

DALLAS, Jan. 12, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first patient with Parkinson’s disease (PD) has been dosed with UB-312 in Part B of a double-blinded, placebo-controlled Phase 1 clinical trial, following completion of Part A of the Phase 1 trial in healthy volunteers. UB-312 is a synthetic peptide vaccine targeting toxic forms of aggregated α-synuclein (aSyn), a protein that plays a central role in synaptic functions and regulation of neurotransmitter release at the synapse. Mutations of aSyn increase the risk of developing PD and other synucleinopathies, including dementia with Lewy bodies (DLB) as well as multiple system atrophy (MSA). UB-312 was granted an orphan designation for MSA by the...

Dallas, Texas, Jan. 12, 2022 (GLOBE NEWSWIRE) — Puration, Inc. (OTC Pink: PURA) today announced the company will publish a strategic overview presentation next week on Tuesday, January 18th covering the company’s 2022 plan to achieve a forecasted $1 million in revenue and reach for a potential $10 million in revenue.  The presentation will include the latest on PURA’s backing from UC Asset LP (OTCQX: UCASU) to construct the Farmersville Hemp Brand facility central to PURA’s updated business plan.  UCASU is a diversified real estate investment company.  UCASU has recently entered the cannabis real estate investment sector.  UCASU also recently announced plans to uplist to Nasdaq or the NYSE. For more information on Puration, visit http://www.purationinc.com Disclaimer: This News Release contains forward-looking statements within...

Executives from Walmart, Gallup, Momentive, VICE Media Group and more join Zoom Leaders in Powerful Discussions to Help Businesses Tackle Work Evolution SAN JOSE, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) — Today, Zoom Video Communications, Inc. (NASDAQ: ZM) announced its first Work Transformation Summit that will provide actionable insights to help businesses navigate what the transformation and future of work means as we move into another year of powerful growth and change. Additionally, the Work Transformation Summit will offer several interactive opportunities for business leaders to learn how to create a successful remote, hybrid, or in-person working environment moving forward. The half-day, virtual-only event scheduled for January 19, 2022, will feature industry-leading guest speakers, including Donna Morris, Chief People Officer...